📋 Tender Overview
Loblaw Companies Limited TSX L Loblaw or the Company announced its unaudited financial results for the fourth quarter ended December 28 2019 and the release of its 2019 Annual Report Financial Review Annual Report. The report includes the Companys audited consolidated financial statements and Managements Discussion and Analysis MDA for the fiscal year ended December 28 2019. The Companys 2019 Annual Report will be available in the Investors section of the Companys website at loblaw.ca and will be filed on SEDAR and available at sedar.com.Our sales trajectory continued to improve through the fourth quarter completing a year in which we achieved our financial targets and made significant strategic investments said Galen G. Weston Executive Chairman Loblaw Companies Limited. We will continue these investments through 2020 positioning Loblaw to deliver long-term shareholder value.2019 FOURTH QUARTER HIGHLIGHTSUnless otherwise indicated the following highlights represent the Companys results from Continuing Operations and include the impacts of spin-out related depreciation the implementation of IFRS 16 Leases IFRS 16 and the consolidation of franchises. See Other Business Matters of this News Release for more information on the spin-out related depreciation and the implementation of IFRS 16.Revenue was 11590 million. When compared to the fourth quarter of 2018 this represented an increase of 372 million or 3.3.Retail segment sales were 11321 million. When compared to the fourth quarter of 2018 this represented an increase of 345 million or 3.1.Food retail Loblaw same-store sales growth was 1.9. Food retail same-store sales growth was approximately 0.8 after excluding the favourable impact of the timing of Thanksgiving.Drug retail Shoppers Drug Mart same-store sales growth was 3.9 with pharmacy same-store sales growth of 6.1 and front store same-store sales growth of 2.2. The timing of Thanksgiving had a nominal impact on same-store sales growth for Drug retail in the fourth quarter of 2019.Operating income was 541 million. When compared to the fourth quarter of 2018 this represented an increase of 96 million or 21.6.Operating income included the year-over-year favourable impact of the implementation of IFRS 16 of approximately 73 million and the total unfavourable impact of spin-out related depreciation of approximately 21 million. Normalized for these impacts operating income increased by 44 million or 9.9.Adjusted EBITDA2 was 1205 million. When compared to the fourth quarter of 2018 this represented an increase of 310 million or 34.6.Adjusted EBITDA2 included the year-over-year favourable impact of the implementation of IFRS 16 of 285 million. Normalized for this impact adjusted EBITDA2 increased by 25 million or 2.8.